| Adapted treatment guided by interim PET-CT scan in advanced Hodgkin’s lymphoma P Johnson, M Federico, A Kirkwood, A Fosså, L Berkahn, A Carella, ... New England Journal of Medicine 374 (25), 2419-2429, 2016 | 821 | 2016 |
| Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial KM Ardeshna, W Qian, P Smith, N Braganca, L Lowry, P Patrick, J Warden, ... The lancet oncology 15 (4), 424-435, 2014 | 439 | 2014 |
| Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study … PJ Hoskin, L Lowry, A Horwich, A Jack, B Mead, BW Hancock, P Smith, ... Journal of Clinical Oncology 27 (32), 5390-5396, 2009 | 229 | 2009 |
| Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial B Patel, AA Kirkwood, A Dey, DI Marks, AK McMillan, TF Menne, ... Leukemia 31 (1), 58-64, 2017 | 117 | 2017 |
| Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial RA Anderson, R Remedios, AA Kirkwood, P Patrick, L Stevens, ... The Lancet Oncology 19 (10), 1328-1337, 2018 | 84 | 2018 |
| Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG–PET data for clinical trials in lymphoma SF Barrington, JE Mackewn, P Schleyer, PK Marsden, NG Mikhaeel, ... Annals of oncology 22 (3), 739-745, 2011 | 74 | 2011 |
| Phase II study of gemcitabine and bexarotene (GEMBEX) in the treatment of cutaneous T-cell lymphoma T Illidge, C Chan, N Counsell, S Morris, J Scarisbrick, D Gilson, B Popova, ... British journal of cancer 109 (10), 2566-2573, 2013 | 49 | 2013 |
| Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study AV Moorman, E Barretta, ER Butler, EJ Ward, K Twentyman, AA Kirkwood, ... Leukemia 36 (3), 625-636, 2022 | 44 | 2022 |
| How do you pray to God? Fragmentation and variety in early medieval Christianity A Pluskowski, P Patrick The cross goes north: processes of conversion in northern Europe, AD, 300-1300, 2003 | 44 | 2003 |
| Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma S Rule, G Cook, NH Russell, A Hunter, S Robinson, N Morley, A Sureda, ... British Journal of Haematology 184 (6), 999-1005, 2019 | 34 | 2019 |
| Results of the 2nd planned interim analysis of the RAPID trial (involved field radiotherapy versus no further treatment) in patients with clinical stages 1A and 2A Hodgkin … J Radford, M O'Doherty, S Barrington, W Qian, P Patrick, S Coltart, ... Blood 112 (11), 369, 2008 | 32 | 2008 |
| RESPONSE‐ADJUSTED THERAPY FOR ADVANCED HODGKIN LYMPHOMA (RATHL) TRIAL: LONGER FOLLOW UP CONFIRMS EFFICACY OF DE‐ESCALATION AFTER a NEGATIVE INTERIM PET SCAN (CRUK/07/033). J Trotman, A Fosså, M Federico, L Stevens, A Kirkwood, L Clifton‐Hadley, ... Hematological Oncology 35, 65-67, 2017 | 29 | 2017 |
| Can baseline PET‐CT features predict outcomes in advanced Hodgkin lymphoma? A prospective evaluation of UK patients in the RATHL trial (CRUK/07/033) LC Pike, AA Kirkwood, P Patrick, J Radford, C Burton, L Stevens, ... Hematological Oncology 35, 37-38, 2017 | 26 | 2017 |
| Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre … DI Marks, AA Kirkwood, CJ Rowntree, M Aguiar, KE Bailey, B Beaton, ... The Lancet Haematology 9 (4), e262-e275, 2022 | 24 | 2022 |
| Approaches to violent death: a case study from early medieval Cambridge P Patrick International Journal of Osteoarchaeology 16 (4), 347-354, 2006 | 21 | 2006 |
| In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission … DI Marks, L Clifton-Hadley, M Copland, J Hussain, TF Menne, A McMillan, ... The Lancet Haematology 9 (4), e276-e288, 2022 | 19 | 2022 |
| The Obese Medieval Monk: A multidisciplinary study of a stereotype P Patrick Archaeopress, 2014 | 18 | 2014 |
| First analysis of the UKALL14 randomized trial to determine whether the addition of nelarabine to standard chemotherapy improves event free survival in adults with T-cell acute … CJ Rowntree, AA Kirkwood, L Clifton-Hadley, N Farah, MR Mansour, ... Blood 138, 366, 2021 | 16 | 2021 |
| Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ … T Creasey, E Barretta, SL Ryan, E Butler, AA Kirkwood, D Leongamornlert, ... Haematologica 107 (9), 2051, 2022 | 12 | 2022 |
| First analysis of the UKALL14 phase 3 randomised trial to determine if the addition of rituximab to standard induction chemotherapy improves EFS in adults with precursor B-ALL … DI Marks, AA Kirkwood, CJ Rowntree, M Aguiar, KE Bailey, B Beaton, ... Blood 134, 739, 2019 | 12 | 2019 |